Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
J Assoc Res Otolaryngol ; 25(3): 259-275, 2024 Jun.
Article En | MEDLINE | ID: mdl-38622383

PURPOSE: Cisplatin is a low-cost clinical anti-tumor drug widely used to treat solid tumors. However, its use could damage cochlear hair cells, leading to irreversible hearing loss. Currently, there appears one drug approved in clinic only used for reducing ototoxicity associated with cisplatin in pediatric patients, which needs to further explore other candidate drugs. METHODS: Here, by screening 1967 FDA-approved drugs to protect cochlear hair cell line (HEI-OC1) from cisplatin damage, we found that Tedizolid Phosphate (Ted), a drug indicated for the treatment of acute infections, had the best protective effect. Further, we evaluated the protective effect of Ted against ototoxicity in mouse cochlear explants, zebrafish, and adult mice. The mechanism of action of Ted was further explored using RNA sequencing analysis and verified. Meanwhile, we also observed the effect of Ted on the anti-tumor effect of cisplatin. RESULTS: Ted had a strong protective effect on hair cell (HC) loss induced by cisplatin in zebrafish and mouse cochlear explants. In addition, when administered systemically, it protected mice from cisplatin-induced hearing loss. Moreover, antitumor studies showed that Ted had no effect on the antitumor activity of cisplatin both in vitro and in vivo. RNA sequencing analysis showed that the otoprotective effect of Ted was mainly achieved by inhibiting phosphorylation of ERK. Consistently, ERK activator aggravated the damage of cisplatin to HCs. CONCLUSION: Collectively, these results showed that FDA-approved Ted protected HCs from cisplatin-induced HC loss by inhibiting ERK phosphorylation, indicating its potential as a candidate for preventing cisplatin ototoxicity in clinical settings.


Antineoplastic Agents , Cisplatin , Hearing Loss , Organophosphates , Oxazoles , Zebrafish , Animals , Cisplatin/toxicity , Cisplatin/adverse effects , Mice , Hearing Loss/prevention & control , Hearing Loss/chemically induced , Oxazoles/pharmacology , Organophosphates/toxicity , Antineoplastic Agents/toxicity , United States Food and Drug Administration , Drug Approval , Hair Cells, Auditory/drug effects , United States , Ototoxicity/prevention & control , Ototoxicity/etiology , Humans
2.
Proc Natl Acad Sci U S A ; 117(13): 7245-7254, 2020 03 31.
Article En | MEDLINE | ID: mdl-32170011

Lens transparency is established by abundant accumulation of crystallin proteins and loss of organelles in the fiber cells. It requires an efficient translation of lens messenger RNAs (mRNAs) to overcome the progressively reduced transcriptional activity that results from denucleation. Inappropriate regulation of this process impairs lens differentiation and causes cataract formation. However, the regulatory mechanism promoting protein synthesis from lens-expressed mRNAs remains unclear. Here we show that in zebrafish, the RNA-binding protein Rbm24 is critically required for the accumulation of crystallin proteins and terminal differentiation of lens fiber cells. In the developing lens, Rbm24 binds to a wide spectrum of lens-specific mRNAs through the RNA recognition motif and interacts with cytoplasmic polyadenylation element-binding protein (Cpeb1b) and cytoplasmic poly(A)-binding protein (Pabpc1l) through the C-terminal region. Loss of Rbm24 reduces the stability of a subset of lens mRNAs encoding heat shock proteins and shortens the poly(A) tail length of crystallin mRNAs encoding lens structural components, thereby preventing their translation into functional proteins. This severely impairs lens transparency and results in blindness. Consistent with its highly conserved expression in differentiating lens fiber cells, the findings suggest that vertebrate Rbm24 represents a key regulator of cytoplasmic polyadenylation and plays an essential role in the posttranscriptional control of lens development.


Crystallins/metabolism , Lens, Crystalline/metabolism , RNA-Binding Proteins/metabolism , Zebrafish Proteins/metabolism , Animals , Cataract/metabolism , Crystallins/genetics , Cytoplasm/metabolism , Models, Animal , Polyadenylation , RNA Processing, Post-Transcriptional , RNA, Messenger/metabolism , RNA-Binding Proteins/genetics , Transcription Factors/metabolism , Zebrafish/metabolism , Zebrafish Proteins/genetics
3.
Asian J Androl ; 19(5): 561-566, 2017.
Article En | MEDLINE | ID: mdl-27624986

Polychlorinated biphenyls (PCBs) are common environmental contaminants that represent a considerable risk to reproductive toxicity in exposed human populations. Although some experimental studies have suggested an association between the levels of PCBs and semen quality, the direct effects of PCBs on human sperm parameters remain largely unexplored. To this aim, a short-term in vitro incubation experiment that better imitated the putative exposure of sperm to Aroclor 1254 (a commercial PCB mixture) in male reproduction tissue was conducted. Human sperm were incubated with various concentrations (0, 1, 5, or 25 mg l-1) of Aroclor 1254 for different amounts of time (3 and 6 h) in vitro. Sperm motility parameters were analyzed with computer-assisted sperm analysis (CASA). The proportion of sperm with high mitochondrial membrane potential (ΔΨm) and the levels of intracellular reactive oxygen species (ROS) were detected to explore the probable cause of sperm impairment. Human sperm exposed to continuous Aroclor 1254 exhibited: (i) reduced sperm motility and kinematic parameters, (ii) a proportion of sperm with high ΔΨm that decreased in a dose-dependent manner (P < 0.05), and (iii) increased levels of ROS compared with controls (P < 0.05). In conclusion, Aroclor 1254 can decrease sperm motility, which may culminate in increased ROS and general mitochondrial dysfunction, thus affecting the fertilization potential of sperm. Our findings suggest a broader understanding of the effect of Aroclor 1254 on human sperm.


/toxicity , Environmental Pollutants/toxicity , Sperm Motility/drug effects , Adult , Biomechanical Phenomena , Dose-Response Relationship, Drug , Humans , In Vitro Techniques , Male , Membrane Potential, Mitochondrial , Mitochondria/drug effects , Reactive Oxygen Species/metabolism
4.
PLoS One ; 10(8): e0135818, 2015.
Article En | MEDLINE | ID: mdl-26275143

Acrylamide (ACR) is a chemical compound with severe neurotoxicity, genotoxicity, carcinogenicity and reproductive toxicity. Recent studies showed that ACR impairs the function of reproductive organs, e.g., epididymis and testes. In vitro maturation of mouse oocyte is a sensitive assay to identify potential chemical hazard to female fertility. The aim of this study was to evaluate the adverse effects of ACR on the nuclear maturation and cumulus cells apoptosis of mouse oocytes in vitro. Cumulus-oocyte complexes were incubated in a maturation medium containing 0, 5, 10 and 20 µM of ACR. Chromosome alignment and spindle morphology of oocytes was determined by immunofluorescence and confocal microscopy. Our results showed that oocytes exposed to different doses of ACR in vitro were associated with a significant decrease of oocyte maturation, significant increase of chromosome misalignment rate, occurrence of abnormal spindle configurations, and the inhibition of oocyte parthenogenetic activation. Furthermore, apoptosis of cumulus cells was determined by TUNEL and CASPASE-3 assay. Results showed that apoptosis in cumulus cells was enhanced and the expression of CASPASE-3 was increased after cumulus-oocyte complexes were exposed to ACR. Therefore, ACR may affect the nuclear maturation of oocytes via the apoptosis of cumulus cells in vitro.


Acrylamide/toxicity , Apoptosis/drug effects , Cell Nucleus/metabolism , Cumulus Cells/metabolism , Oocytes/metabolism , Animals , Caspase 3/biosynthesis , Cell Nucleus/pathology , Chromosomes, Mammalian/metabolism , Cumulus Cells/pathology , Dose-Response Relationship, Drug , Female , Gene Expression Regulation, Enzymologic/drug effects , Mice , Mice, Inbred ICR , Oocytes/pathology , Spindle Apparatus/metabolism , Spindle Apparatus/pathology
...